Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
Authors
Keywords
-
Journal
Journal of Ophthalmology
Volume 2017, Issue -, Pages 1-4
Publisher
Hindawi Limited
Online
2017-03-02
DOI
10.1155/2017/5632634
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
- (2016) Ehsan Rahimy et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
- (2015) Jo�o Pinheiro-Costa et al. OPHTHALMOLOGICA
- Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
- (2014) Heidi Fassnacht-Riederle et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2014) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
- (2013) Vincent Y. Ho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
- (2013) Hyung Cho et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
- (2012) Diana V. Do et al. OPHTHALMOLOGY
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment
- (2012) Michael J. Elman et al. OPHTHALMOLOGY
- The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema
- (2011) Diana V. Do et al. OPHTHALMOLOGY
- The RESTORE Study
- (2011) Paul Mitchell et al. OPHTHALMOLOGY
- Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2010) Quan Dong Nguyen et al. OPHTHALMOLOGY
- A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
- (2010) Michel Michaelides et al. OPHTHALMOLOGY
- An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema
- (2009) D V Do et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
- (2009) J. Fernando Arevalo et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search